Home Newsfeeds CEL-SCI Q3 EPS $(0.23) Up From $(0.25) YoY

CEL-SCI Q3 EPS $(0.23) Up From $(0.25) YoY

CEL-SCI (AMEX:CVM) reported quarterly losses of $(0.23) per share. This is a 8 percent increase over losses of $(0.25) per share from the same period last year.

byBenzinga Newsdesk

August 15, 2022

1 minute read

CEL-SCI (AMEX:CVM) reported quarterly losses of $(0.23) per share. This is a 8 percent increase over losses of $(0.25) per share from the same period last year.

Inquiry Into Advanced Micro Devices’s Competitor Dynamics In Semiconductors & Semiconductor Equipment Industry

By Benzinga Insights

April 3, 11:00 AM

In the fast-paced and cutthroat world of business, conducting thorough company analysis is essential for investors and industry…

AMD

Annovis Bio Showcases Promising Progress In Novel Drug Development At The 2023 Clinical Trials On Alzheimer’s Disease Conference

By Benzinga Newsdesk

October 24, 9:15 AM

Annovis Bio, Inc. (NYSE:ANVS), a late-stage clinical drug platform company developing transformative therapies to treat neurodegenerative diseases, including Alzheimer's Disease (AD) and Parkinson's Disease (PD), is

ANVS